DK147597B - PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES - Google Patents

PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES Download PDF

Info

Publication number
DK147597B
DK147597B DK583670A DK583670A DK147597B DK 147597 B DK147597 B DK 147597B DK 583670 A DK583670 A DK 583670A DK 583670 A DK583670 A DK 583670A DK 147597 B DK147597 B DK 147597B
Authority
DK
Denmark
Prior art keywords
added
mixture
stirred
ethyl acetate
temperature
Prior art date
Application number
DK583670A
Other languages
Danish (da)
Other versions
DK147597C (en
Inventor
Kazuo Kariyone
Hirokichi Harada
Masaru Kurita
Hisatoyo Yazawa
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK147597B publication Critical patent/DK147597B/en
Application granted granted Critical
Publication of DK147597C publication Critical patent/DK147597C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

147597147597

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af 7-aminocephalosporansyrederivater med den almene formel IThe present invention relates to a particular process for the preparation of 7-aminocephalosporanoic acid derivatives of the general formula I

R-X-CH2-C0NH i i o^~Y^ ch2-BiR-X-CH 2 -CONH i i o ^ ~ Y ^ ch 2-Bi

000H000h

hvor R1 betegner azido, thiadiazolylthio eller oxadiazolylthio, hvor thiadiazol- og oxadiazolkernerne eventuelt er substitueret med C.j_g-5 alkyl eller C^_g-alkylthio, eller tetrazolylthio, hvor tetrazolkernerne eventuelt er substitueret med C^_g-alkyl, X betegner et svovl- eller oxygenatom eller en enkeltbinding, og R2 betegner halogen eller sydnyl, tetrazolyl, oxadiazolyl, thienyl, phenyl eller thiadiazolyl, hvilke grupper eventuelt er substitueret med C^_g-alkyl eller C^_g-10 alkylthio, idet dog sydnyl og tetrazolyl kun er eventuelt substitueret med C.j_g-alkyl, når X betegner svovl eller oxygen, med det forbehold, at når R2 er halogen, angiver X en enkeltbinding, eller salte deraf, hvorved man omsætter en forbindelse med den almene formel IIwherein R 1 represents azido, thiadiazolylthio or oxadiazolylthio, wherein the thiadiazole and oxadiazole nuclei are optionally substituted with C 1-6 alkyl or C 1-6 alkylthio, or tetrazolylthio, where the tetrazole cores are optionally substituted with C 1-6 alkyl, X is bet - or oxygen atom or a single bond, and R 2 represents halogen or sydnyl, tetrazolyl, oxadiazolyl, thienyl, phenyl or thiadiazolyl, which groups are optionally substituted with C 1-6 alkyl or C 1-6 alkylthio, with however, Sydnyl and tetrazolyl are optionally substituted with C 1-6 alkyl when X represents sulfur or oxygen, with the proviso that when R 2 is halogen, X represents a single bond, or salts thereof, thereby reacting a compound of general formula II

^rYs> H00C-CH- (OH«) »-C0NH ^ A χχ | 1 KH2 0 2^ rYs> H00C-CH- (OH «)» -C0NH ^ A χχ | 1 KH2 0 2

C00HC00H

hvor R1 har den ovenfor anførte betydning, med chlortrimethylsilan i 15 nærværelse af en base eller omsætter et salt af forbindelsen med den almene formel II med chlortrimethylsilan, omsætter den resulterende 2 147597wherein R 1 has the meaning given above, with chlorotrimethylsilane in the presence of a base or reacting a salt of the compound of the general formula II with chlorotrimethylsilane, reacting the resulting 2

forbindelse med et halogeneringsmiddel og omsætter den herved vund-ne forbindelse med en lavere alkanol, hvilken fremgangsmåde er ejendommelig ved, at den herved vundne forbindelse med den almene formel Vcompound with a halogenating agent and reacting the resulting compound with a lower alkanol, the process being characterized in that the resulting compound having the general formula V

. S.. S.

(CH3)3Si-OOC-CH-(CH2)5-C=N—|-f > γ(CH3) 3Si-OOC-CH- (CH2) 5-C = N- | -f> γ

Le5 Lrψ HLe5 Lrψ H

0 COOSi(CH3)30 COOSi (CH3) 3

5 hvor Rl har den ovenfor anførte betydning, R3 betegner hydrogen eller (CHgigSi-, og R* betegner lavere alkyl, derefter omsættes med en forbindelse med den almene formel VI5 wherein R 1 is as defined above, R 3 is hydrogen or (CH 2 S 5, and R 1 is lower alkyl, then reacted with a compound of general formula VI

r2-x-ch2-cooh VIr2-x-ch2-cooh VI

hvor R* og X har de ovenfor anførte betydninger, i nærværelse af et 10 kondenseringsmiddel, eller forbindelsen V omsættes med et reaktivt carboxylgruppederivat af forbindelsen med den almene formel VI i nærværelse af en organisk base, hvorefter den herved opnåede forbindelse hydrolyseres.wherein R * and X have the above meanings, in the presence of a condensing agent, or the compound V is reacted with a reactive carboxyl group derivative of the compound of the general formula VI in the presence of an organic base, after which the compound obtained is hydrolyzed.

Ved "C^_g-alkyl" skal her forstås en lige eller forgrenet carbonhy-15 dridgruppe, fx methyl, ethyl, propyl, isopropyl, butyl, isobutyl eller pentyl.By "C 1-6 alkyl" is meant herein a straight or branched hydrocarbon group, for example methyl, ethyl, propyl, isopropyl, butyl, isobutyl or pentyl.

De som udgangsstoffer anvendte forbindelser med den almene formel II fx 7-(5-aminoadipinamido)-3-(1-methyl-1H-tetrazol-5-yl)-thiomethyl-3-cephem-4-carboxylsyre, kan fremstilles som beskrevet i hollandsk 20 patentansøgning nr. 6.805.179 eller i analogi dermed.The starting compounds of general formula II, for example 7- (5-aminoadipinamido) -3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-3-cephem-4-carboxylic acid, can be prepared as described in Dutch patent application No. 6,805,179 or in analogy thereof.

Forbindelser med den almene formel I kendes, fx fra hollandsk patentansøgning nr. 6.805.179, i henhold til hvilken fx 7-(1H-tetrazol- 3 147597 1-yl)-acetamido-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-ceph-em-4-carboxylsyre fremstilles ved hydrolyse af 7-(5-aminoadipinami-do) -3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyI-3-cephem-4-carboxyl-syre (som svarer til en udgangsforbindelse med den almene formel II 5 ved den her omhandlede fremgangsmåde) og efterfølgende omsætning af den resulterende 7-amino-3-(5-methyM ,3,4-th iadiazol-2-y 1)-th io-methyl-3-cephem-4-carboxylsyre med 1H-tetrazol-1 -eddikesyre. Ved denne kendte metode er man nødt til at isolere 7-amino-3-(5-methyl- 1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxyIsyre som mellem-10 produkt, da den efterfølgende reaktion ellers ikke kan udføres, og dette forårsager denne kendte reaktionsfølges komplexicitet og fører til det lavere udbytte af den ønskede forbindelse.Compounds of general formula I are known, for example, from Dutch Patent Application No. 6,805,179, according to which, for example, 7- (1H-tetrazol-3-yl) -acetamido-3- (5-methyl-1,3, 4-Thiadiazol-2-yl) -thiomethyl-3-ceph-em-4-carboxylic acid is prepared by hydrolysis of 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazole-2 -yl) -thiomethyl-3-cephem-4-carboxylic acid (corresponding to a starting compound of the general formula II 5 by the process herein) and subsequent reaction of the resulting 7-amino-3- (5-methylM 3,4-thiadiazol-2-yl) -thio-methyl-3-cephem-4-carboxylic acid with 1H-tetrazole-1-acetic acid. In this known method, it is necessary to isolate 7-amino-3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylic acid as intermediate, since otherwise, the subsequent reaction cannot be carried out and this causes the complexity of this known reaction sequence and leads to the lower yield of the desired compound.

Ved fremgangsmåden ifølge den foreliggende opfindelse fås direkte den ønskede forbindelse med den almene formel I i et højere udbytte 15 uden isolering af mellemprodukterne, dvs. forbindelserne med formlerne Ilf, IV, V og VII (jf. s. 6-7).In the process of the present invention, the desired compound of general formula I is obtained directly in a higher yield 15 without isolating the intermediates, i.e. the compounds of formulas Ilf, IV, V and VII (cf. pp. 6-7).

Ved fremgangsmåden ifølge den foreliggende opfindelse omsættes først en forbindelse med den almene formel II med chlortrimethylsilan i nærværelse af en base, eller et salt af forbindelsen med den almene 20 formel II omsættes med chlortrimethylsilan.In the process of the present invention, a compound of the general formula II is first reacted with chlorotrimethylsilane in the presence of a base, or a salt of the compound of the general formula II is reacted with chlorotrimethylsilane.

I de anvendte udgangsforbindelser med den almene formel II kan R1 være azido, thiadiazolylthio (fx 1,3,4-thiadiazolylthio, 1,2,5-thiadia-zolylthio eller 1,3,5-thiadiazolylthio), oxadiazolylthio (fx 1,3,4-oxadi-azolyithio, 1,2,5-oxadiazolylthio eller 1,3,5-oxadiazolylthio) eller 25 tetrazolylthio (fx 1H-tetrazolylthio eller 2H-tetrazolylthio).In the starting compounds of general formula II, R 1 may be azido, thiadiazolylthio (e.g., 1,3,4-thiadiazolylthio, 1,2,5-thiadiazolylthio or 1,3,5-thiadiazolylthio), oxadiazolylthio (e.g., 1.3 , 4-oxadiazolylthio, 1,2,5-oxadiazolylthio or 1,3,5-oxadiazolylthio) or tetrazolylthio (e.g., 1H-tetrazolylthio or 2H-tetrazolylthio).

Som eksempler på salte af forbindelsen med den almene formel II kan nævnes alkalimetalsalte såsom natrium- eller kaliumsaltene, jordalkali-metalsalte, fx calcium- eller magnesiumsaltene, eller de organiske tert.amin-salte, fx triethylamin, trimethylamin, N-methylpiperazin- el-30 ler pyridinsaltene.Examples of salts of the compound of general formula II include the alkali metal salts such as the sodium or potassium salts, the alkaline earth metal salts, e.g., the calcium or magnesium salts, or the organic tertiary amine salts, e.g., triethylamine, trimethylamine, N-methylpiperazine or the like. 30 clays the pyridine salts.

Eksempler på baser, der kan anvendes ved omsætning af forbindelsen med den almene formel II med chlortrimethylsilan, er sådanne baser, 4 147597 som kan danne et salt med forbindelsen med den almene formel II, nærmere bestemt sådanne baser som hydroxider, carbonater, bicarbo-nater, alkoxider eller hydrider af alkalimetaller, fx af kalium eller natrium, alkoxider, carbonater, bicarbonater og hydrider af jordalka-5 limetaller, fx af calcium eller magnesium, eller organiske tertiære aminer, fx trimethylamin, triethylamin, N-methylpiperazin eller pyri-din.Examples of bases which may be used in the reaction of the compound of general formula II with chlorotrimethylsilane are those bases which can form a salt of the compound of general formula II, in particular such bases as hydroxides, carbonates, bicarbonates , alkoxides or hydrides of alkali metals, eg of potassium or sodium, alkoxides, carbonates, bicarbonates and hydrides of alkaline earth metals, eg of calcium or magnesium, or organic tertiary amines, for example trimethylamine, triethylamine, N-methylpiperazine or pyridine.

Reaktionen udføres sædvanligvis i et opløsningsmiddel såsom chloro-form, dichlormethan eller et hvilket som helst andet opløsningsmiddel, 10 som er inert under reaktionsbetingelserne. Reaktionen udføres for trinsvis i området fra stuetemperatur op til 40°C, men reaktionstemperaturen er i øvrigt ikke kritisk. Chlortrimethylsilan anvendes fortrinsvis i en mængde på over 3 mol pr. mol af forbindelsen med den almene formel II. Det foretrækkes at anvende forbindelsen med den 15 almene formel II i vandfri form eller at anvende chlortrimethylsilan i en tilstrækkelig mængde til at eliminere det vand, som indeholdes i forbindelsen med den almene formel II.The reaction is usually carried out in a solvent such as chloroform, dichloromethane or any other solvent which is inert under the reaction conditions. The reaction is carried out for stepwise in the range of room temperature up to 40 ° C, but the reaction temperature is not otherwise critical. Chlorotrimethylsilane is preferably used in an amount greater than 3 moles per ml. moles of the compound of general formula II. It is preferred to use the compound of general formula II in anhydrous form or to use chlorotrimethylsilane in a sufficient amount to eliminate the water contained in the compound of general formula II.

Den på denne måde fremstillede forbindelse (III) isoleres ikke, men underkastes behandling med et halogeneringsmiddel. Eksempler på 20 egnede halogeneringsmidler er phosphortrichlorid, phosphorpentachlo-rid, phosphortribromid, phosphorpentabromid, phosphoroxychlorid, phosgen eller thionylchlorid. Reaktionstemperaturen er ikke kritisk, men reaktionen udføres sædvanligvis under afkøling.The compound (III) thus prepared is not isolated, but subjected to treatment with a halogenating agent. Examples of suitable halogenating agents are phosphorus trichloride, phosphorus pentachloride, phosphorus tribromide, phosphorus pentabromide, phosphorus oxychloride, phosgene or thionyl chloride. The reaction temperature is not critical, but the reaction is usually carried out under cooling.

Den på denne måde fremstillede forbindelse (IV) isoleres ikke, men 25 omsættes med en lavere alkanol. Eksempler på sådanne lavere alkano-ler er methanol, ethanol, propanol, butanol og pentanol. Reaktionstemperaturen er ikke kritisk, men reaktionen udføres sædvanligvis i et område fra stuetemperatur og ned til afkølingstemperatur.The compound (IV) thus prepared is not isolated, but reacted with a lower alkanol. Examples of such lower alkanols are methanol, ethanol, propanol, butanol and pentanol. The reaction temperature is not critical, but the reaction is usually carried out in a range from room temperature down to cooling temperature.

Den på denne måde fremstillede forbindelse (V) isoleres ikke, men 30 omsættes med en forbindelse med den almene formel VI i nærværelse af et kondenseringsmiddel, eller omsættes med et reaktivt derivat af forbindelsen med formlen VI i nærværelse af en organisk base. Forbindelsen med en carboxylgruppe er en forbindelse med formlen VI, 5 147597 hvor R2X- kan være halogen, fx chlor eller brom, sydnylthio, fx sydnon-4-ylthio, sydnyloxy, fx sydnon-4-yloxy, sydnyl, tetrazolyl, fx 1H-tetrazolyl eller 2H-tetrazolyl, tetrazolylthio, fx 1H-tetrazolylthio eller 2H-tetrazolylthio, tetrazolyloxy, fx 1 H-tetrazolyloxy eller 2H-te-5 trazolyloxy, oxadiazolyl, fx 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl eller 1.3.5- oxadiazolyl, oxadiazolylthio, fx 1,3,4-oxadiazolylthio, 1,2,5-oxa-diazolylthio eller 1,3,5-oxadiazolylthio, oxadiazolyloxy, fx 1,3,4-oxa-diazolyloxy, 1,2,5-oxadiazolyloxy eller 1,3,5-oxadiazolyloxy, thienyl, thienylthio, thienyloxy, phenyl, phenylthio, phenyloxy, thiadiazolyl, 10 fx 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl eller 1,3,5-thiadiazolyl, thia-diazolylthio, fx 1,2,5-thiadiazolylthio, 1,3,4-thiadiazolylthio eller 1.3.5- thiadiazolylthio, og thiadiazolyloxy, fx 1,2,5-thiadiazolyloxy, 1,3,4-thiadiazolyloxy eller 1,3,5-thiadiazolyloxy.The compound (V) thus prepared is not isolated, but is reacted with a compound of general formula VI in the presence of a condensing agent, or reacted with a reactive derivative of the compound of formula VI in the presence of an organic base. The compound having a carboxyl group is a compound of formula VI, wherein R2X- may be halogen, e.g. chloro or bromo, sydnylthio, eg sydnon-4-ylthio, sydnyloxy, eg sydnon-4-yloxy, sydnyl, tetrazolyl, e.g. tetrazolyl or 2H-tetrazolyl, tetrazolylthio, eg 1H-tetrazolylthio or 2H-tetrazolylthio, tetrazolyloxy, eg 1H-tetrazolyloxy or 2H-tetrazolyloxy, oxadiazolyl, eg 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl or 1,3,5-oxadiazolyl, oxadiazolylthio, e.g., 1,3,4-oxadiazolylthio, 1,2,5-oxa-diazolylthio, or 1,3,5-oxadiazolylthio, oxadiazolyloxy, e.g., 1,3,4-oxa-diazolyloxy, e.g. , 2,5-oxadiazolyloxy or 1,3,5-oxadiazolyloxy, thienyl, thienylthio, thienyloxy, phenyl, phenylthio, phenyloxy, thiadiazolyl, e.g., 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl or 1.3 , 5-thiadiazolyl, thia-diazolylthio, e.g., 1,2,5-thiadiazolylthio, 1,3,4-thiadiazolylthio or 1,3,5-thiadiazolylthio, and thiadiazolyloxy, e.g., 1,2,5-thiadiazolyloxy, thiadiazolyloxy or 1,3,5-thiadiazolyloxy.

Eksempler på de ovennævnte reaktive carboxylgruppederivater af for-15 bindeiserne med den almene formel VI er syreanhydrider, fx blandede anhydrider med lavere alkylcarbonater eller aliphatiske carboxylsyrer, syrechlorider eller aktive estere, fx cyanmethylestere, pentachlorphe-nylestere, methoxymethylestere, vinylestere, 1-methoxyvinylestere, 1-ethoxyvinylestere, propargy I estere, p-chlorphenylestere og trichlor-20 phenylestere.Examples of the above reactive carboxyl group derivatives of the compounds of general formula VI are acid anhydrides, e.g. mixed anhydrides with lower alkyl carbonates or aliphatic carboxylic acids, acid chlorides or active esters, e.g. -ethoxyvinyl esters, propargy I esters, p-chlorophenyl esters and trichlorophenyl esters.

Eksempler på organiske baser, der kan anvendes ved denne omsætning er triethylamin, Ν,Ν-dimethylbenzylamin og pyridin. Eksempler på kondenseringsmidler, der kan anvendes ved omsætningen, er alkylsubstituerede pyridiner, N,N-di-cyclohexylcarbodiimid eller 25 Ν,Ν-diisopropylcarbodiimid. Omsætningen udføres fortrinsvis ved en temperatur mellem stuetemperatur og opvarmningstemperatur.Examples of organic bases that can be used in this reaction are triethylamine, Ν, Ν-dimethylbenzylamine and pyridine. Examples of condensing agents which can be used in the reaction are alkyl-substituted pyridines, N, N-di-cyclohexylcarbodiimide or 25 Ν, di-diisopropylcarbodiimide. The reaction is preferably carried out at a temperature between room temperature and heating temperature.

Det er muligt at anvende reaktionsblandingen fra det foregående trin som udgangsmateriale. Det foretrækkes som udgangsmateriale ved denne omsætning at anvende en reaktionsblanding, hvorfra overskud 30 af halogeneringsmiddel og lavere alkanol er afdestilleret under formindsket tryk. Såfremt der anvendes en reaktionsblanding, hvorfra overskud af halogeneringsmiddel ikke er fjernet, foretrækkes det før reaktionen at opvarme denne reaktionsblanding til fjernelse af overskud af halogeneringsmiddel og overskud af lavere alkanol eller alter- 6 147597 nativt at tilsætte en overskydende mængde dimethylformamid til reaktionsblandingen til eliminering af overskuddet af halogeneringsmiddel.It is possible to use the reaction mixture from the previous step as starting material. It is preferred as starting material for this reaction to use a reaction mixture from which excess 30 of halogenating agent and lower alkanol is distilled off under reduced pressure. If a reaction mixture is used from which excess halogenating agent has not been removed, it is preferable, prior to the reaction, to heat this reaction mixture to remove excess halogenating agent and excess alkanol or alternatively to add an excess amount of dimethylformamide to the reaction mixture. the excess of halogenating agent.

Den på denne måde fremstillede forbindelse (VII) isoleres ikke, men underkastes hydrolyse. Hydrolyseringsreaktionen udføres sædvanligvis 5 ved, at reaktionsblandingen fra det foregående trin hældes ud i vand, fortrinsvis i nærværelse af en syre såsom fortyndet saltsyre eller eddikesyre, eller en base, fx et alkalimetalbicarbonat eller en trialkylamin. Den resulterende forbindelse, 7-aminocephalosporansyre-derivatet med den almene formel I, kan isoleres og renses på konven-10 tionel måde.The compound (VII) thus prepared is not isolated but subjected to hydrolysis. The hydrolyzing reaction is usually carried out by pouring the reaction mixture from the previous step into water, preferably in the presence of an acid such as dilute hydrochloric acid or acetic acid, or a base, for example an alkali metal bicarbonate or a trialkylamine. The resulting compound, the 7-aminocephalosporanoic acid derivative of general formula I, can be isolated and purified in conventional manner.

De her omhandlede reaktioner udføres fortrinsvis under vandfrie betingelser med undtagelse af den til sidst foretagne hydrolysereaktion.The reactions of the present invention are preferably carried out under anhydrous conditions with the exception of the last hydrolysis reaction.

Det formodes, at mellemprodukterne III, IV, V og VII, der fremkommer ved de omhandlede reaktioner, kan vises ved følgende formler, 15 hvor X, R1, R2 har de ovenfor anførte betydninger, R3 betegner hydrogen eller (CHgJgSi-, Y betegner halogen, Z" betegner en anion, og R* betegner lavere alkyl:It is believed that the intermediates III, IV, V and VII resulting from the above reactions can be represented by the following formulas, wherein X, R1, R2 have the meanings given above, R3 represents hydrogen or (CH , Z "represents an anion and R * represents lower alkyl:

(CH3)3Si-00C-CH-(CH2)5-00NH—-ζ S N(CH3) 3Si-00C-CH- (CH2) 5-00NH —- ζ S N

HH-R3 J Jv 111 0 ^ 7 CH.-R1 COOSi(CH3)5HH-R3 J Jv 111 0 ^ 7 CH.-R1 COOSi (CH3) 5

(CH,),Si-00C-CH-(CH9),-C=N—j-S S N(CH,), Si-00C-CH- (CH9), - C = N-j-S S N

1 , 3 I Dr JL IV1, 3 In Dr. JL IV

1 cr^ OHj-R1 COOSi(CH3)3 (CH3)3Si-00C-CH-(CH2)3-C=N—|-<Snj I , I i NH-R3 0-R4)/ ^GHg-R1 0 COOSi(CH3)3 7 147597 ra-R5 (OH,),Si-OOC-CH-(CHg),-C-O-R4 \1 Cr ^ OHj-R1 COOSi (CH3) 3 (CH3) 3Si-00C-CH- (CH2) 3-C = N - | - <Snj I, I in NH-R3 0-R4) / ^ GHg-R1 0 COOSi (CH3) 3 77575 ra-R5 (OH,), Si-OOC-CH- (CHg), - CO-R4 \

2 vv + S2 vv + S

R -X-CH2-C0H--{ N VIIR -X-CH 2 -COH - {N VII

XCH2-R1 7Γ COOSi(CH3)3XCH2-R1 7Γ COOSi (CH3) 3

Fremgangsmåden ifølge opfindelsen belyses nærmere ved følgende eksempler: EKSEMPEL 1 2,5 g 7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thio-5 methyl-3-cephem-4-carboxylsyre suspenderes i 50 ml dichlormethan.The process of the invention is further illustrated by the following examples: EXAMPLE 1 2.5 g of 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thio-5-methyl-3- cephem-4-carboxylic acid is suspended in 50 ml of dichloromethane.

Der tilsættes 0,6 ml triethylamin, 3 ml chlortrimethylsilan og 4,3 ml Ν,Ν-dimethyIanilin. Blandingen omrøres i 1 time ved stuetemperatur, hvorefter der tilsættes 2,1 g phosphorpentachlorid ved -60°C. Blandingen omrøres i 2 1/2 time ved en temperatur mellem -40 og -50°C.0.6 ml of triethylamine, 3 ml of chlorotrimethylsilane and 4.3 ml of Ν, Ν-dimethylaniline are added. The mixture is stirred for 1 hour at room temperature, then 2.1 g of phosphorus pentachloride is added at -60 ° C. The mixture is stirred for 2 1/2 hours at a temperature between -40 and -50 ° C.

10 Der tilsættes 0,3 ml Ν,Ν-dimethylanilin og 18 ml n-butanol, og blandingen omræres i 1 time ved en temperatur mellem -40 og -50°C. Di-chlormethanet afdestilleres under formindsket tryk ved stuetemperatur, og remanensen koncentreres under formindsket tryk (2 mm Hg) ved 40°C. Remanensen suspenderes i 20 ml dichlormethan, og der 15 tilsættes under afkøling 5,1 ml triethylamin. Blandingen omrøres i 15 minutter ved stuetemperatur, hvorpå der under afkøling tilsættes det blandede syreanhydrid, der dannes ved anvendelse af 1,9 g IH-tetra- 8 147597 zol-1-eddikesyre, 2,1 ml triethylamin, 1,7 g trimethylacetylchlorid og 40 ml tetrahydrofuran. Den resulterende blanding omrøres i 15 timer ved stuetemperatur, og opløsningsmidlet afdestilleres under formindsket tryk. Remanensen hældes ud i vand, og den vandige opløsning 5 ekstraheres med ethylacetat, hvorpå ethylacetatfasen ekstraheres med en mættet vandig opløsning af natriumbicarbonat. Til ekstrakten sættes ethylacetat, og blandingen syrnes ved tilsætning af saltsyre. Ethylacetatfasen fraskilles, vaskes med vand og tørres over magnesiumsulfat. Ethylacetatet afdestilleres under formindsket tryk. Rema-10 nensen opløses i ethylacetat, og til opløsningen sættes ether. Bundfaldet samles ved filtrering, hvorved der fås 0,23 g gullige krystaller af 7- (1 H-tetrazol-1 -yl) -acetamido-3- (5-methyl-l ,3,4-thiadiazol-2-yl) - thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 130-140°C (sønderdeling). UV-Spektrum (phosphatpuffer ved pH-værdi 6,4): X 272 ΓΠ9Χ 15 nm, ε| 0 = 230. lem EKSEMPEL 2 2,5 g 7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thio-methyl-3-cephem-4-carboxylsyre suspenderes i dichlormethan. Der tilsættes 0,6 ml triethylamin, 4 ml chlortrimethylsiian og 4,3 ml N,N-di-20 methylanilin. Blandingen omrøres i 1 time ved stuetemperatur, hvorpå der tilsættes 2,1 g phosphorpentachlorid ved -60°C. Blandingen omrøres i 2 1/2 time ved en temperatur meilem -40 og -50°C. Der tilsættes 0,3 ml Ν,Ν-dimethylanilin og 18 ml n-butanol, og blandingen omrøres i 1 time ved en temperatur mellem -40°C og -50°C. Dichlormethanet 25 afdestilleres under formindsket tryk ved stuetemperatur, og remanensen koncentreres under formindsket tryk (2 mm Hg) ved 40°C. Remanensen suspenderes i 20 ml dichlormethan, og der tilsættes 5,1 ml triethylamin under afkøling. Blandingen omrøres i 15 minutter ved stuetemperatur, hvorpå der under afkøling tilsættes det blandede sy-30 reanhydrid, der fås under anvendelse af 1,9 g phenyleddikesyre, 2,1 ml triethylamin, 1,7 g trimethylacetylchlorid og 40 ml tetrahydrofuran.0.3 ml of Ν, Ν-dimethylaniline and 18 ml of n-butanol are added and the mixture is stirred for 1 hour at a temperature between -40 and -50 ° C. The dichloromethane is distilled off under reduced pressure at room temperature and the residue is concentrated under reduced pressure (2 mm Hg) at 40 ° C. The residue is suspended in 20 ml of dichloromethane, and 15 ml, with cooling, 5.1 ml of triethylamine are added. The mixture is stirred for 15 minutes at room temperature and then, with cooling, the mixed acid anhydride formed using 1.9 g of 1H-tetra-1-acetic acid, 2.1 ml of triethylamine, 1.7 g of trimethylacetyl chloride and 40 ml of tetrahydrofuran. The resulting mixture is stirred for 15 hours at room temperature and the solvent is distilled off under reduced pressure. The residue is poured into water and the aqueous solution is extracted with ethyl acetate, then the ethyl acetate phase is extracted with a saturated aqueous solution of sodium bicarbonate. To the extract is added ethyl acetate and the mixture is acidified by addition of hydrochloric acid. The ethyl acetate phase is separated, washed with water and dried over magnesium sulfate. The ethyl acetate is distilled off under reduced pressure. The residue is dissolved in ethyl acetate and ether is added to the solution. The precipitate is collected by filtration to give 0.23 g of yellow crystals of 7- (1H-tetrazol-1-yl) -acetamido-3- (5-methyl-1,3,4-thiadiazol-2-yl) - thiomethyl-3-cephem-4-carboxylic acid, mp 130-140 ° C (dec.). UV Spectrum (Phosphate Buffer at pH 6.4): X 272 ΓΠ9Χ 15 nm, ε | Example 230 2.5 g of 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thio-methyl-3-cephem-4-carboxylic acid suspended in dichloromethane. Add 0.6 ml of triethylamine, 4 ml of chlorotrimethylsilane and 4.3 ml of N, N-dimethylaniline. The mixture is stirred for 1 hour at room temperature, then 2.1 g of phosphorus pentachloride is added at -60 ° C. The mixture is stirred for 2 1/2 hours at a temperature between -40 and -50 ° C. 0.3 ml of Ν, Ν-dimethylaniline and 18 ml of n-butanol are added and the mixture is stirred for 1 hour at a temperature between -40 ° C and -50 ° C. The dichloromethane 25 is distilled off under reduced pressure at room temperature and the residue is concentrated under reduced pressure (2 mm Hg) at 40 ° C. The residue is suspended in 20 ml of dichloromethane and 5.1 ml of triethylamine is added under cooling. The mixture is stirred for 15 minutes at room temperature and then, with cooling, the mixed acid anhydride obtained using 1.9 g of phenylacetic acid, 2.1 ml of triethylamine, 1.7 g of trimethylacetyl chloride and 40 ml of tetrahydrofuran is added.

Blandingen omrøres i 15 timer, og opløsningsmidlet afdestilleres under formindsket tryk. Remanensen hældes ud i vand, og den vandige opløsning ekstraheres med ethylacetat, idet ekstrakten på sin side U7597 g ekstraheres med mættet vandig opløsning af kaliumbicarbonat, og der sættes vand til ekstrakten. Ekstrakten syrnes ved tilsætning af koncentreret saltsyre, hvorpå ethylacetatfasen fraskilles, vaskes med vand og tørres over magnesiumsulfat. Ethylacetatet afdestilleres under 5 formindsket tryk, hvorved der fås 1,35 g af en remanens. Denne remanens opløses i ethylacetat, og der tilsættes ether til ethylacetatfasen. Bundfaldet samles ved filtrering, hvorved der fås 0,47 g bleg gulligrøde krystaller af 7-phenyiacetamido-3-(5-methyl-1,3,4-thiadia-zol-2-yl)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 160-165°C 10 (sønderdeling). UV-Spektrum (95% ethanol): Xmgx = 274 nm, = 245.The mixture is stirred for 15 hours and the solvent is distilled off under reduced pressure. The residue is poured into water and the aqueous solution is extracted with ethyl acetate, the extract in turn U7597 g being extracted with saturated aqueous solution of potassium bicarbonate and water being added to the extract. The extract is acidified by the addition of concentrated hydrochloric acid, whereupon the ethyl acetate phase is separated, washed with water and dried over magnesium sulfate. The ethyl acetate is distilled off under reduced pressure to give 1.35 g of a residue. This residue is dissolved in ethyl acetate and ether is added to the ethyl acetate phase. The precipitate is collected by filtration to give 0.47 g of pale yellow-red crystals of 7-phenylacetamido-3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4 carboxylic acid, mp 160-165 ° C (dec.). UV Spectrum (95% ethanol): Xmgx = 274 nm, = 245.

EKSEMPEL 3 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxylat sættes til 50 ml dichlormethan.EXAMPLE 3 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are added to 50 ml of dichloromethane. .

15 Der tilsættes 0,6 ml triethylamin, 10 ml chlortrimethylsilan og 4,3 ml Ν,Ν-dimethylanilin, og blandingen omrøres i 1 time under tilbagesvaling. 2,1 g phosphorpentachlorid sættes til blandingen, som afkøles med en blanding af tøris og acetone, og derefter tilsættes 0,3 g Ν,Ν-dimethylanilin og 15 ml absolut n-propanol ved samme temperatur.Add 0.6 ml of triethylamine, 10 ml of chlorotrimethylsilane and 4.3 ml of Ν, Ν-dimethylaniline and stir the mixture for 1 hour under reflux. 2.1 g of phosphorus pentachloride is added to the mixture, which is cooled with a mixture of dry ice and acetone, and then 0.3 g of Ν, Ν-dimethylaniline and 15 ml of absolute n-propanol are added at the same temperature.

20 Blandingen omrøres i 30 minutter ved samme temperatur og derefter i 30 minutter ved stuetemperatur. Til blandingen sættes 5,5 ml triethylamin, og der omrøres i 15 minutter ved stuetemperatur, hvorpå opløsningsmidlet afdestilleres under formindsket tryk. En opløsning, der er fremstillet ved at opløse den på denne måde vundne remanens i 50 25 ml dichlormethan og tilsætning af 4 ml triethylamin, sættes til en opløsning, der er fremstillet ved at omrøre en opløsning af 3,2 g 1H-te-trazol-1-eddikesyre, 3,5 g (chlormethylen)-dimethylenammoniumchlorid og 4 ml dimethylformamid i 20 ml dichlormethan i 1 time ved stuetemperatur og tilsætte 4,5 g triethylamin dertil under afkøling med en 30 blanding af tøris og acetone under efterfølgende omrøring af blandingen i 30 minutter ved samme temperatur. Den resulterende blanding omrøres i 2 timer, idet temperaturen lidt efter lidt får lov at stige til -20°C, og derefter afdestilleres opløsningsmidlet. Remanensen hældes ud i vand, og den vandige opløsning indstilles til pH-værdi 1,5 og 147597 ίο ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand og ek-straheres 3 gange med vand mættet med kaliumbicarbonatopløsning.The mixture is stirred for 30 minutes at the same temperature and then for 30 minutes at room temperature. To the mixture is added 5.5 ml of triethylamine and stirred for 15 minutes at room temperature, whereupon the solvent is distilled off under reduced pressure. A solution prepared by dissolving the residue thus obtained in 50 ml of dichloromethane and the addition of 4 ml of triethylamine is added to a solution prepared by stirring a solution of 3.2 g of 1H-tetrazole -1-acetic acid, 3.5 g (chloromethylene) dimethylene ammonium chloride and 4 ml dimethylformamide in 20 ml dichloromethane for 1 hour at room temperature and add 4.5 g triethylamine thereto under cooling with a mixture of dry ice and acetone with subsequent stirring of the mixture for 30 minutes at the same temperature. The resulting mixture is stirred for 2 hours, gradually allowing the temperature to rise to -20 ° C and then distilling off the solvent. The residue is poured into water and the aqueous solution is adjusted to pH 1.5 and extracted with ethyl acetate. The ethyl acetate phase is washed with water and extracted 3 times with water saturated with potassium bicarbonate solution.

Den vandige opløsning vaskes med ethylacetat og indstilles på neutral reaktion ved tilsætning af koncentreret saltsyre i nærværelse af 5 ethylacetat. Ethylacetatfasen vaskes to gange med vand og tørres over magnesiumsulfat. Opløsningsmidlet afdestilleres, hvorpå den olieagtige remanens vaskes med ether og opløses i ethylacetat. Til opløsningen sættes ether under afkøling, og bundfaldet vaskes med ether og tørres, hvorved der fås 0,933 g bleggullige krystaller af 10 7-(1H-tetrazol-l-yl)-acetamido-3-(5-methyl-1,3,4-thiadiazoI-2-yl)-thio-methyl-3-cephem-4-carboxylsyre, smeltepunkt 129-138°C.The aqueous solution is washed with ethyl acetate and adjusted to neutral reaction by the addition of concentrated hydrochloric acid in the presence of ethyl acetate. The ethyl acetate phase is washed twice with water and dried over magnesium sulfate. The solvent is distilled off and the oily residue is washed with ether and dissolved in ethyl acetate. To the solution is added ether under cooling and the precipitate is washed with ether and dried to give 0.933 g of pale yellow crystals of 7- (1H-tetrazol-1-yl) -acetamido-3- (5-methyl-1,3,4). -thiadiazo-2-yl) -thio-methyl-3-cephem-4-carboxylic acid, mp 129-138 ° C.

EKSEMPEL 4 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiometyl-3-cephem-4-carboxyIat suspenderes i 50 ml dichlormeth-15 an, og til blandingen sættes 0,6 ml triethylamin, 7 ml chlortrimethyl-silan og 4,3 ml Ν,Ν-dimethylanilin. Blandingen omrøres i 1 time under tilbagesvaling, hvorpå der tilsættes phosphorpentachlorid under afkøling ved -50°C med en blanding af acetone og tøris. Blandingen omrøres i 2 timer ved samme temperatur, hvorpå der tilsættes en 20 opløsning af 0,3 ml Ν,Ν-dimethylanilin i 16 ml methanol. Den resulterende blanding omrøres i 30 minutter ved stuetemperatur. Til blandingen sættes under afkøling 5 ml triethylamin, og der omrøres i 15 minutter, hvorpå opløsningsmidlet afdestilleres under formindsket tryk. Til remanensen sættes 40 ml dichlormethan. Denne opløsning 25 sættes til en opløsning, der er fremstillet ved at omrøre en opløsning af 3 g dicyclohexylcarbodiimid og 3,84 g 1H-tetrazol-1-eddikesyre i 30 ml tetrahydrof uran under afkøling i 1 time. Den resulterende opløsning omrøres i 1 time ved 0-5°C og derefter i 1 time ved stuetemperatur. Opløsningsmidlet afdampes under formindsket tryk, og til 30 remanensen sættes vand, hvorpå den vandige opløsning ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand og ekstraheres med vand, der er mættet med kaliumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, tørres 11 147597 og koncentreres ved destillation. Den olieagtige remanens behandles med ether, hvorved der fås 1,124 g krystaller af 7-(lH-tetrazol-l-yl)-acetamido-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem- 4-carboxylsyre.Example 4 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 50 ml of dichloromethane -15 an, and to the mixture are added 0.6 ml of triethylamine, 7 ml of chlorotrimethylsilane and 4.3 ml of Ν, Ν-dimethylaniline. The mixture is stirred for 1 hour under reflux, then phosphorus pentachloride is added under cooling at -50 ° C with a mixture of acetone and dry ice. The mixture is stirred for 2 hours at the same temperature, then a solution of 0.3 ml of Ν, Ν-dimethylaniline in 16 ml of methanol is added. The resulting mixture is stirred for 30 minutes at room temperature. To the mixture is added, under cooling, 5 ml of triethylamine and stirred for 15 minutes, after which the solvent is distilled off under reduced pressure. To the residue is added 40 ml of dichloromethane. This solution 25 is added to a solution prepared by stirring a solution of 3 g of dicyclohexylcarbodiimide and 3.84 g of 1 H-tetrazole-1-acetic acid in 30 ml of tetrahydro uranium under cooling for 1 hour. The resulting solution is stirred for 1 hour at 0-5 ° C and then for 1 hour at room temperature. The solvent is evaporated under reduced pressure, and to the residue is added water, and the aqueous solution is extracted with ethyl acetate. The ethyl acetate phase is washed with water and extracted with potassium bicarbonate saturated water. The extract is acidified by addition of hydrochloric acid and extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated by distillation. The oily residue is treated with ether to give 1.124 g of crystals of 7- (1H-tetrazol-1-yl) -acetamido-3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl 3-cephem-4-carboxylic acid.

5 EKSEMPEL 5 0,6 ml triethylamin, 6 ml chlortrimethylsilan og 4,3 ml N,N-dimethyl-anilin sættes til en opløsning af 2,55 g natrium-7-(5-aminoadipinami-do) -3-(5-methyM,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxy-lat i 50 ml dichlormethan. Blandingen omrøres i 1 time'under tilbage-10 svaling, og der tilsættes under kraftig omrøring ved -50°C 2,1 g phosphorpentachlorid. Den resulterende blanding omrøres yderligere i 2 timer ved samme temperatur, hvorpå der under afkøling ved -20°C tilsættes en blanding af 0,3 ml Ν,Ν-dimethylanilin og 15 ml methanol.EXAMPLE 5 0.6 ml of triethylamine, 6 ml of chlorotrimethylsilane and 4.3 ml of N, N-dimethyl-aniline are added to a solution of 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5- methyl, 3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate in 50 ml of dichloromethane. The mixture is stirred for 1 hour under reflux and 2.1 g of phosphorus pentachloride is added under vigorous stirring at -50 ° C. The resulting mixture is further stirred for 2 hours at the same temperature and then, with cooling at -20 ° C, a mixture of 0.3 ml of Ν, Ν-dimethylaniline and 15 ml of methanol is added.

Opløsningen omrøres i 30 minutter ved en temperatur mellem -40 og 15 -50°C og derefter i 30 minutter ved stuetemperatur, hvorpå opløs ningsmidlet afdestilleres under formindsket tryk. Remanensen suspenderes i 50 ml dichlormethan, og der tilsættes 6 ml triethylamin under afkøling ved en temperatur mellem -10 og -15°C. Blandingen omrøres i 10 minutter, og der tilsættes 4 g thiophen-2-acetylchlorid. Blandingen 20 omrøres i 2 timer ved den samme temperatur, og opløsningsmidlet afdestilleres under formindsket tryk. Remanensen hældes ud i vand, og den vandige opløsning ekstraheres med ethylacetat. Ekstrakten vaskes med vand og ekstraheres med vand, der er mættet med kali-umbicarbonat. Den vandige opløsning syrnes ved tilsætning af salt-25 syre under afkøling, vaskes med vand, der er mættet med natrium-chlorid, og tørres. Opløsningsmidlet afdestilleres under formindsket tryk. Remanensen behandles med ether, hvorved der fås 1,33 g krystaller af 7-(2-thienyl)-acetamido-3-(5-methyl-1,3,4~thiadiazol-2-yl)-thiomethy!-3-cephem-4-carboxylsyre. IR-Spektrum (nujol): 3300, 30 1780, 1720, 1655 og 1530 cm'1.The solution is stirred for 30 minutes at a temperature between -40 and 15 -50 ° C and then for 30 minutes at room temperature, whereupon the solvent is distilled off under reduced pressure. The residue is suspended in 50 ml of dichloromethane and 6 ml of triethylamine is added under cooling at a temperature between -10 and -15 ° C. The mixture is stirred for 10 minutes and 4 g of thiophene-2-acetyl chloride is added. The mixture 20 is stirred for 2 hours at the same temperature and the solvent is distilled off under reduced pressure. The residue is poured into water and the aqueous solution is extracted with ethyl acetate. The extract is washed with water and extracted with water saturated with potassium bicarbonate. The aqueous solution is acidified by the addition of hydrochloric acid with cooling, washed with water saturated with sodium chloride and dried. The solvent is distilled off under reduced pressure. The residue is treated with ether to give 1.33 g of crystals of 7- (2-thienyl) -acetamido-3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem -4-carboxylic acid. IR Spectrum (nujol): 3300, 1780, 1720, 1655 and 1530 cm -1.

12 147597 EKSEMPEL 6 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol- 2-yI)-thiomethyl-3-cephem-4-carboxyIat suspenderes i 30 ml dichlor-methan, og der tilsættes 0,4 ml triethylamin, 30 ml N,N-dimethylanilin 5 og 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under tilbagesvaling, og 2,2 g phosphorpentachlorid tilsættes under afkøling ved -50°C. Blandingen omrøres i 2 timer ved samme temperatur, og der tilsættes 0,3 ml Ν,Ν-dimethylanilin og 15 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur mellem -50 og -40°C og i 30 10 minutter ved stuetemperatur. Reaktionsblandingen koncentreres under formindsket tryk, og til remanensen sættes 30 ml dichlormethan. Den resulterende blanding sættes på én gang til en opløsning, der er fremstillet ved at omsætte 2,0 g 1H-tetrazol-1-eddikesyre med 1,9 g pivaloylchlorid i en opløsning af 2,2 ml triethylamin og 50 ml tetra-15 hydrofuran, under afkøling ved en temperatur mellem -5 og 0°C. Umiddelbart derefter tilsættes 5,5 ml triethylamin til blandingen ved samme temperatur, og blandingen omrøres i 1 time ved denne temperatur, hvorpå den henstår natten over. Opløsningsmidlet afdampes under formindsket tryk, og til remanensen sættes vand. Den vandige 20 opløsning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, hvorpå den ekstraheres med vand, som er mættet med natriumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre til pH-værdi 2,0 og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natrium-25 chlorid, tørres og koncentreres under formindsket tryk. Den olieag-tige remanens vaskes med ether, hvorved der fås 1,19 g af et gulligt pulver af 7-(1 H-tetrazol-1 -yl) -acetamido-3-(5-methyl-1,3,4-thiadiazol- 2-yl)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 95-100°C.EXAMPLE 6 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are suspended for 30 minutes. ml of dichloromethane, and 0.4 ml of triethylamine, 30 ml of N, N-dimethylaniline 5 and 4.0 ml of chlorotrimethylsilane are added. The mixture is stirred for 1 hour under reflux and 2.2 g of phosphorus pentachloride is added under cooling at -50 ° C. The mixture is stirred for 2 hours at the same temperature and 0.3 ml of Ν, Ν-dimethylaniline and 15 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The reaction mixture is concentrated under reduced pressure and 30 ml of dichloromethane are added to the residue. The resulting mixture is added at once to a solution prepared by reacting 2.0 g of 1H-tetrazole-1-acetic acid with 1.9 g of pivaloyl chloride in a solution of 2.2 ml of triethylamine and 50 ml of tetrahydrofuran , under cooling at a temperature between -5 and 0 ° C. Immediately thereafter, 5.5 ml of triethylamine are added to the mixture at the same temperature and the mixture is stirred for 1 hour at this temperature, where it is left to stand overnight. The solvent is evaporated under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water saturated with sodium chloride and then extracted with water saturated with sodium bicarbonate. The extract is acidified by adding hydrochloric acid to pH 2.0 and extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 1.19 g of a yellow powder of 7- (1H-tetrazol-1-yl) -acetamido-3- (5-methyl-1,3,4-thiadiazole) - 2-yl) -thiomethyl-3-cephem-4-carboxylic acid, mp 95-100 ° C.

EKSEMPEL 7 30 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazoI-2- yl)-thiomethyl-3-cephem-4-carboxylat suspenderes i 30 ml dichlormethan, og til suspensionen sættes 0,4 ml triethylamin, 30 ml N,N-dimeth-ylanilin og 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time 13 147597 under tilbagesvaling, hvorpå der under afkøling ved en temperatur mellem -50 og -40°C tilsættes 2,2 g phosphorpentachlorid. Blandingen omrøres i 2 timer ved samme temperatur, og der tilsættes 0,3 ml Ν,Ν-dimethylanilin og 15 ml methanol. Blandingen omrøres derefter i 5 30 minutter ved en temperatur mellem -50 og -40°C og i 30 minutter ved stuetemperatur. Efter tilsætning af 2,5 ml triethylamin koncentreres reaktionsblandingen under formindsket tryk, og til remanensen sættes 30 ml dichlormethan. Den resulterende blanding sættes på én gang til en opløsning, der er fremstillet ved at behandle 2,75 g 10 1,3,4-thiadiazol-2-thioeddikesyre med 1,9 g pivaloylchlorid i en blan ding af 2,2 ml triethylamin og 50 ml tetrahyd rof uran i 1 time under afkøling ved en temperatur mellem -5 og 0°C og defter tilsætte 3,0 ml triethylamin. Reaktionsblandingen omrøres i 1 time ved samme temperatur og henstår derefter natten over. Opløsningsmidlet afdestilleres 15 under formindsket tryk, og til remanensen sættes vand. Den vandige opløsning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand. Ethylacetatfasen ekstraheres med vand, der er mættet med natriumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre under afkøling og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med 20 vand, der er mættet med natriumchlorid, tørres og koncentreres under formindsket tryk. Den olieagtige remanens vaskes med ether, hvorved der fås 0,549 g af et gulligt pulver af 7-(1,3,4-thiadiazol- 2-yl)-thioacetamido-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 90-95°C.EXAMPLE 7 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 30 ml. dichloromethane, and to the suspension are added 0.4 ml of triethylamine, 30 ml of N, N-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at a temperature between -50 and -40 ° C. The mixture is stirred for 2 hours at the same temperature and 0.3 ml of Ν, Ν-dimethylaniline and 15 ml of methanol are added. The mixture is then stirred for 5 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. After the addition of 2.5 ml of triethylamine, the reaction mixture is concentrated under reduced pressure and 30 ml of dichloromethane are added to the residue. The resulting mixture is added at once to a solution prepared by treating 2.75 g of 1,3,4-thiadiazole-2-thioacetic acid with 1.9 g of pivaloyl chloride in a mixture of 2.2 ml of triethylamine and 50 ml of tetrahydro uranium for 1 hour under cooling at a temperature between -5 and 0 ° C and then add 3.0 ml of triethylamine. The reaction mixture is stirred for 1 hour at the same temperature and then left overnight. The solvent is distilled off under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water. The ethyl acetate phase is extracted with water saturated with sodium bicarbonate. The extract is acidified by addition of hydrochloric acid under cooling and extracted with ethyl acetate. The ethyl acetate phase is washed with 20 saturated sodium chloride water, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 0.549 g of a yellow powder of 7- (1,3,4-thiadiazol-2-yl) -thioacetamido-3- (5-methyl-1,3,4-thiadiazole). 2-yl) -thiomethyl-3-cephem-4-carboxylic acid, m.p. 90-95 ° C.

25 EKSEMPEL 8 2,55 g natrium-7-(5-aminoadipinamido)-3-(1 -methyl-1H-tetrazol-5-yl)-thiomethyl-3-cephem-4-carboxylat suspenderes i 30 ml dichlormethan, og til suspensionen sættes 0,4 ml triethylamin, 3,0 ml Ν,Ν-dimethylanilin og 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under 30 tilbagesvaling, hvorpå der under afkøling ved en temperatur mellem -50 og -40°C tilsættes 2,2 g phosphorpentachlorid. Den resulterende blanding omrøres i 2 timer ved samme temperatur, hvorpå der tilsættes 3,0 ml Ν,Ν-dimethylanilin og 15 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur mellem -50 og -40°C og i 30 minutter 14 147597 ved stuetemperatur. Reaktionsblandingen koncentreres under formindsket tryk, og til remanensen sættes 30 ml dichlormethan og 5,5 mi triethylamin. Den resulterende blanding sættes til en opløsning af 2,5 g 2-thienylacetylchlorid i 50 ml tetrahyd rof uran ved en temperatur 5 mellem -5 og 0°C, og reaktionsblandingen omrøres i 1 time ved stuetemperatur og henstår derefter natten over. Opløsningsmidlet afdestil-leres under formindsket tryk, og til remanensen sættes vand. Den vandige opløsning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand, hvorpå den ekstraheres med vand, der er mættet 10 med natriumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, tørres og koncentreres under formindsket tryk. Den olieagtige remanens vaskes med ether, hvorved der fås 0,249 g pulverformet 7-(2-thienyl)-acetamido-3-n-methyl-1H-15 tetrazoI-5-yI)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 87-91°C.EXAMPLE 8 2.55 g of sodium 7- (5-aminoadipinamido) -3- (1-methyl-1H-tetrazol-5-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 30 ml of dichloromethane and added The suspension is added 0.4 ml of triethylamine, 3.0 ml of Ν, Ν-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at a temperature between -50 and -40 ° C. The resulting mixture is stirred for 2 hours at the same temperature, then 3.0 ml of ml, Ν-dimethylaniline and 15 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The reaction mixture is concentrated under reduced pressure and 30 ml of dichloromethane and 5.5 ml of triethylamine are added to the residue. The resulting mixture is added to a solution of 2.5 g of 2-thienylacetyl chloride in 50 ml of tetrahydro-uranium at a temperature between 5 and 0 ° C, and the reaction mixture is stirred for 1 hour at room temperature and then left overnight. The solvent is distilled off under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water and then extracted with water saturated with sodium bicarbonate. The extract is acidified by addition of hydrochloric acid and extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 0.249 g of powdered 7- (2-thienyl) -acetamido-3-n-methyl-1H-tetrazol-5-yl) -thiomethyl-3-cephem-4-carboxylic acid, m.p. 87-91 ° C.

EKSEMPEL 9 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methy!thio-1,3,4-thiadia-zol-2-yI)-thiomethyl-3-cephem-4-carboxylat suspenderes i 30 ml di-20 chlormethan, og til suspensionen sættes 0,3 ml triethylamin, 2,2 ml Ν,Ν-dimethylanilin og 3,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under tilbagesvaling, og 1,0 g phosphorpentachlorid tilsættes under afkøling ved en temperatur mellem -40 og -50°C. Den resulterende blanding omrøres i 2 timer ved samme temperatur, og der 25 tilsættes 0,15 ml Ν,Ν-dimethylanilin og 7,5 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur mellem -50 og -40°C og i 30 minutter ved stuetemperatur. Blandingen koncentreres ved formindsket tryk, og til remanensen sættes 30 ml dichlormethan og 2,3 ml triethylamin. Den resulterende blanding sættes til en opløsning, der 30 er fremstillet ved at behandle en opløsning af 1,76 g sydnon-3-eddi-kesyre i 50 ml tetrahydrofuran med en opløsning af 2,5 g dicyclohe-xylcarbodiimid i 20 ml tetrahydrofuran i 10 minutter under afkøling ved en temperatur mellem -5°C og 0°C. Den resulterende reaktionsblanding omrøres i 1 time ved samme temperatur og henstår derefter 15 147597 natten over. Opløsningsmidlet sidestilleres under formindsket tryk, og til remanensen sættes vand. Den vandige opløsning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand og ekstraheres med vand, der er mættet med natriumbicarbonat. Ekstrakten syrnes ved 5 tilsætning af saltsyre og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, som er mættet med natriumchlorid, tørres og koncentreres under formindsket tryk. Den olieagtige remanens vaskes med ether, hvorved der fås 0,234 g pulverformet 7-(sydnon-3-yl)-acetamido-3-(5-methylthio-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-10 4-carboxylsyre, smeltepunkt 163-168°C.Example 9 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methylthio-1,3,4-thiadiazol-2-yl) thiomethyl-3-cephem-4-carboxylate are suspended. in 30 ml of di-20 chloromethane and to the suspension are added 0.3 ml of triethylamine, 2.2 ml of Ν, Ν-dimethylaniline and 3.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux and 1.0 g of phosphorus pentachloride is added under cooling at a temperature between -40 and -50 ° C. The resulting mixture is stirred for 2 hours at the same temperature and 0.15 ml of Ν, Ν-dimethylaniline and 7.5 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The mixture is concentrated at reduced pressure and 30 ml of dichloromethane and 2.3 ml of triethylamine are added to the residue. The resulting mixture is added to a solution prepared by treating a solution of 1.76 g of sydnon-3-acetic acid in 50 ml of tetrahydrofuran with a solution of 2.5 g of dicyclohexylcarbodiimide in 20 ml of tetrahydrofuran in 10 ml. minutes under cooling at a temperature between -5 ° C and 0 ° C. The resulting reaction mixture is stirred for 1 hour at the same temperature and then left overnight. The solvent is equilibrated under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water and extracted with water saturated with sodium bicarbonate. The extract is acidified by the addition of hydrochloric acid and extracted with ethyl acetate. The ethyl acetate phase is washed with water which is saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 0.234 g of powdered 7- (sydnon-3-yl) -acetamido-3- (5-methylthio-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem -10 4-carboxylic acid, mp 163-168 ° C.

EKSEMPEL 10 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxylat suspenderes i 30 ml dichlormeth-an, og til suspensionen sættes 0,4 ml triethylamin, 3,0 ml N,N-dime-15 thylanilin og 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under tilbagesvaling, hvorpå der under afkøling ved en temperatur mellem -40 og -50°C tilsættes 2,2 g phosphorpentachlorid. Blandingen omrøres i 2 timer ved samme temperatur, og der tilsættes 0,3 ml Ν,Ν-dimethylanilin og 15 ml methanol. Den resulterende blanding om-20 røres i 30 minutter ved en temperatur mellem -50 og -40°C og i 30 minutter ved stuetemperatur. Blandingen koncentreres under formindsket tryk, og til remanensen sættes 15 ml dichlormethan, 50 ml tetra-hydrofuran og 5,5 ml triethylamin. Den resulterende opløsning sættes til en suspension af 2,4 g 2-bromacetylchlorid i 15 ml dichlormethan 25 under afkøling ved en temperatur mellem -5 og 0°C, og reaktionsblandingen omrøres i 3 timer ved samme temperatur og henstår derpå natten over. Opløsningsmidlet afdestilleres under formindsket tryk, og til remanensen sættes vand. Den vandige opløsning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand og ekstraheres der-30 efter med vand, der er mættet med natriumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre under afkøling og ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, tørres og koncentreres under formindsket tryk. Den olieagtige remanens vaskes med ether, hvorved der fås 0,525 g pul- 16 147597 verformet 7-(2-bromacetamido)-3-(5-methyl-1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 135-143°C.EXAMPLE 10 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 30 ml of dichloromethane. -an, and to the suspension are added 0.4 ml of triethylamine, 3.0 ml of N, N-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at a temperature between -40 and -50 ° C. The mixture is stirred for 2 hours at the same temperature and 0.3 ml of Ν, Ν-dimethylaniline and 15 ml of methanol are added. The resulting mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The mixture is concentrated under reduced pressure and to the residue are added 15 ml of dichloromethane, 50 ml of tetrahydrofuran and 5.5 ml of triethylamine. The resulting solution is added to a suspension of 2.4 g of 2-bromoacetyl chloride in 15 ml of dichloromethane 25 under cooling at a temperature between -5 and 0 ° C, and the reaction mixture is stirred for 3 hours at the same temperature and then left overnight. The solvent is distilled off under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water and then extracted with water saturated with sodium bicarbonate. The extract is acidified by addition of hydrochloric acid under cooling and extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 0.525 g of powdered 7- (2-bromoacetamido) -3- (5-methyl-1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem -4-carboxylic acid, mp 135-143 ° C.

EKSEMPEL 11 2,55 g natrium-7-(5-aminoadipinamido)-3-(5-methyl-1,3,4-oxadiazol-2-5 yl)-thiomethyl-3-cephem-4-carboxylat suspenderes i 30 ml dichlorme-than, og til suspensionen sættes 0,4 ml triethylamin, 3,0 ml N,N-di-methylanilin og 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under tilbagesvaling, hvorefter der tilsættes 2,2 g phosphorpenta-chlorid under afkøling ved en temperatur mellem -40 og -50°C. Blan-10 dingen omrøres i 2 timer ved samme temperatur, og der tilsættes 0,3 ml Ν,Ν-dimethylaniIin og 15 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur mellem -50 og -40°C og i 30 minutter ved stuetemperatur. Den resulterende blanding koncentreres under formindsket tryk, og til remanensen sættes 50 ml dichlormethan og 3,0 15 ml triethylamin. Den resulterende opløsning afkøles til en temperatur mellem -10 og -15°C og sættes dråbevis til 4,0 g phenylacetylchlorid, og reaktionsblandingen omrøres i 2 timer ved samme temperatur og henstår derpå natten over. Opløsningsmidlet afdestilleres under formindsket tryk, og til remanensen sættes vand. Den vandige opløsning 20 ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand og ekstraheres videre med vand, der er mættet med natriumbicarbonat.Example 11 2.55 g of sodium 7- (5-aminoadipinamido) -3- (5-methyl-1,3,4-oxadiazol-2-5-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 30 ml. dichloromethane, and to the suspension are added 0.4 ml of triethylamine, 3.0 ml of N, N-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at a temperature between -40 and -50 ° C. The mixture is stirred for 2 hours at the same temperature and 0.3 ml of Ν, Ν-dimethylaniline and 15 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The resulting mixture is concentrated under reduced pressure and 50 ml of dichloromethane and 3.0 ml of triethylamine are added to the residue. The resulting solution is cooled to a temperature between -10 and -15 ° C and added dropwise to 4.0 g of phenylacetyl chloride, and the reaction mixture is stirred for 2 hours at the same temperature and left overnight. The solvent is distilled off under reduced pressure and water is added to the residue. The aqueous solution 20 is extracted with ethyl acetate and the ethyl acetate phase is washed with water and extracted further with water saturated with sodium bicarbonate.

Ekstrakten syrnes ved tilsætning af saltsyre under afkøling og ekstraheres derefter med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, tørres og koncentreres under 25 formindsket tryk. Den olieagtige remanens vaskes med ether, hvorved der fås 0,284 g pulverformet 7-phenylacetamido-3-(5-methyl-1,3,4-oxadiazol“2-yl)-thiomethyl-3-cephem-4-carboxylsyre, smeltepunkt 105-113°C.The extract is acidified by addition of hydrochloric acid under cooling and then extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is washed with ether to give 0.284 g of powdered 7-phenylacetamido-3- (5-methyl-1,3,4-oxadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylic acid, m.p. 113 ° C.

EKSEMPEL 12 30 2,0 g natrium-7-(5-aminoadipinamido)-3-azidomethyl-3-cephem-4-car- boxylat suspenderes i 30 ml dichlormethan, og til suspensionen sættes 17 147597 0,4 ml triethylamin, 3,0 ml N,N-dimethylanilin og 4,0 ml chlortrime-thylsilan. Blandingen omrøres i 1 time under tilbagesvaling, hvorpå der under afkøling ved en temperatur mellem -40 og -50°C tilsættes 2,2 g phosphorpentachlorid. Den resulterende blanding omrøres i 2 5 timer ved samme temperatur, og der tilsættes 0,3 ml N,N-dimethylanilin og 15 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur mellem -50 og -40°C og derefter i 30 minutter ved stuetemperatur. Blandingen koncentreres under formindsket tryk, og til remanensen sættes 50 ml dichlormethan og 3,0 ml triethylamin. Den 10 resulterende opløsning afkøles til en temperatur mellem -5 og 0°C og sættes dråbevis til 1,5 g 3-methyl-1,2,5-oxadiazol-4-acetytchlorid, hvorefter reaktionsblandingen omrøres i 2 timer ved samme temperatur og derpå henstår natten over. Opløsningsmidlet afdampes under formindsket tryk, og til remanensen sættes vand. Den vandige opløs-15 ning ekstraheres med ethylacetat, og ethylacetatfasen vaskes med vand og ekstraheres yderligere med vand, der er mættet med natri-umbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre under afkøling, hvorefter der ekstraheres med ethylacetat. Ethylacetatfasen vaskes med vand, der er mættet med natriumchlorid, tørres og kon-20 centreres under formindsket tryk. Den olieagtige remanens opløses i dichlormethan, og der tilsættes en ringe mængde ether. Blandingen henstår under afkøling. Bundfaldet isoleres ved filtrering og vaskes med ether, hvorved der fås 0,434 g krystaller af 7-(3-methyl-1,2,5-oxadiazol-4-yl)-acetamido-3-azidomethyl-3-cephem-4-carboxylsyre, 25 smeltepunkt 115-120°C.EXAMPLE 12 2.0 g of sodium 7- (5-aminoadipinamido) -3-azidomethyl-3-cephem-4-carboxylate are suspended in 30 ml of dichloromethane and to the suspension 0.4 ml of triethylamine, 3, is added. 0 ml of N, N-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at a temperature between -40 and -50 ° C. The resulting mixture is stirred for 2 hours at the same temperature and 0.3 ml of N, N-dimethylaniline and 15 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and then for 30 minutes at room temperature. The mixture is concentrated under reduced pressure and 50 ml of dichloromethane and 3.0 ml of triethylamine are added to the residue. The resulting solution is cooled to a temperature between -5 and 0 ° C and added dropwise to 1.5 g of 3-methyl-1,2,5-oxadiazole-4-acetyl chloride, then the reaction mixture is stirred for 2 hours at the same temperature and then left over overnight. The solvent is evaporated under reduced pressure and water is added to the residue. The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water and further extracted with water saturated with sodium bicarbonate. The extract is acidified by adding hydrochloric acid under cooling and then extracted with ethyl acetate. The ethyl acetate phase is washed with water saturated with sodium chloride, dried and concentrated under reduced pressure. The oily residue is dissolved in dichloromethane and a small amount of ether is added. The mixture is left to cool. The precipitate is isolated by filtration and washed with ether to give 0.434 g of crystals of 7- (3-methyl-1,2,5-oxadiazol-4-yl) -acetamido-3-azidomethyl-3-cephem-4-carboxylic acid, Mp 115-120 ° C.

EKSEMPEL 13 2,5 g natrium-7-(5-aminoadipinamido)-3-(1,3,4-thiadiazol-2-yl)-thiome-thyl-3-cephem-4-carboxylat suspenderes i 30 ml dichlormethan, og til suspensionen sættes 0,4 ml triethylamin, 3,0 ml N, N-dimethylanilin og 30 4,0 ml chlortrimethylsilan. Blandingen omrøres i 1 time under til bagesvaling, hvorpå der under afkøling ved -50°C tilsættes 2,2 g phosphorpentachlorid. Den resulterende blanding omrøres i 2 timer ved samme temperatur, og der tilsættes 0,3 ml N,N-dimethylanilin og ' 15 ml methanol. Blandingen omrøres i 30 minutter ved en temperatur 18 147597 mellem -50 og -40°C og i 30 minutter ved stuetemperatur. Derpå koncentreres blandingen under formindsket tryk, og til remanensen sættes 30 ml dichlormethan. Den resulterende opløsning sættes på én gang til en opløsning, der er fremstillet ved at behandle 2,7 g 5-me-5 thyl-1,3,4-thiadiazoi-2-oxyeddikesyre med 1,9 g pivaloylchlorid i en blanding af 2,2 ml triethylamin og 50 ml tetrahyd rof uran under afkøling ved en temperatur mellem -5 og 0°C. Umiddelbart derefter tilsættes 3,0 ml triethylamin, og reaktionsblandingen omrøres i 1 time ved samme temperatur og henstår derefter natten over. Opløsningsmidlet 10 afdestilleres under formindsket tryk, og til remanensen sættes vand.EXAMPLE 13 2.5 g of sodium 7- (5-aminoadipinamido) -3- (1,3,4-thiadiazol-2-yl) -thiomethyl-3-cephem-4-carboxylate are suspended in 30 ml of dichloromethane, and To the suspension are added 0.4 ml of triethylamine, 3.0 ml of N, N-dimethylaniline and 4.0 ml of chlorotrimethylsilane. The mixture is stirred for 1 hour under reflux, then 2.2 g of phosphorus pentachloride is added under cooling at -50 ° C. The resulting mixture is stirred for 2 hours at the same temperature and 0.3 ml of N, N-dimethylaniline and 15 ml of methanol are added. The mixture is stirred for 30 minutes at a temperature between -50 and -40 ° C and for 30 minutes at room temperature. The mixture is then concentrated under reduced pressure and 30 ml of dichloromethane are added to the residue. The resulting solution is added at once to a solution prepared by treating 2.7 g of 5-methyl-1,3,4-thiadiazo-2-oxyacetic acid with 1.9 g of pivaloyl chloride in a mixture of 2 , 2 ml of triethylamine and 50 ml of tetrahydro uranium under cooling at a temperature between -5 and 0 ° C. Immediately thereafter, 3.0 ml of triethylamine is added and the reaction mixture is stirred for 1 hour at the same temperature and then left overnight. The solvent 10 is distilled off under reduced pressure and water is added to the residue.

Den vandige opløsning ekstraheres med ethylacetat, og ethylacetat-fasen vaskes med vand og ekstraheres med vand, der er mættet med natriumbicarbonat. Ekstrakten syrnes ved tilsætning af saltsyre under afkøling og ekstraheres med ethylacetat. Ethy I acetatfa s en vaskes med 15 vand, der er mættet med natriumchlorid, tørres og koncentreres under formindsket tryk. Den olieagtige remanens tørres i ether, og der tilsættes yderligere ether, indtil opløsningen bliver hvid, hvorpå opløsningen afkøles. Det dannede bundfald isoleres ved filtrering, hvorved der fås 5,84 g krystaller af 7-(5-methyl-1,3,4-thiadiazol-2-20 yl)-oxyacetamido-3-(1,3,4-thiadiazol-2-yl)-thiomethyl-3-cephem-4-carb-oxylsyre, smeltepunkt 105-110°C.The aqueous solution is extracted with ethyl acetate and the ethyl acetate phase is washed with water and extracted with water saturated with sodium bicarbonate. The extract is acidified by addition of hydrochloric acid under cooling and extracted with ethyl acetate. Ethyl acetate is washed with 15 saturated sodium chloride water, dried and concentrated under reduced pressure. The oily residue is dried in ether and additional ether is added until the solution turns white and the solution is cooled. The precipitate formed is isolated by filtration to give 5.84 g of crystals of 7- (5-methyl-1,3,4-thiadiazol-2-20 yl) oxyacetamido-3- (1,3,4-thiadiazole) 2-yl) -thiomethyl-3-cephem-4-carboxylic acid, mp 105-110 ° C.

Claims (2)

147597147597 1. Fremgangsmåde til fremstilling af 7-aminocephalosporansyrederivater med den almene formel I R2-X-CH2-C0NH—|—f s ^ i f Ny^CH2-Rl COOH hvor R1 betegner azido, thiadiazolylthio eller oxadiazolylthio, hvor 5 thiadiazol- og oxadiazolkernerne eventuelt er substitueret med C.|_g-alkyl eller C^ g-alkylthio, eller tetrazolylthio, hvor tetrazolkernerne eventuelt er substitueret med C^_g-alkyl, X betegner et svovl- eller oxygenatom eller en enkeltbinding, og R2 betegner halogen eller sydnyl, tetrazolyl, oxadiazolyl, thienyl, phenyl eller thiadiazolyl, 10 hvilke grupper eventuelt er substitueret med C^_g-alkyl eller C^_g-alkylthio, idet dog sydnyl og tetrazolyl kun er eventuelt substitueret med C^_g-alkyl, når X betegner svovl eller oxygen, med det forbehold, at når R2 er halogen, angiver X en enkeltbinding, eller salte deraf, hvorved man omsætter en forbindelse med den almene formel II hooc-ch-(ch2)3-conh--τ' SS I L_N J 11 ^ 1 2. gh2-r COOHA process for the preparation of 7-aminocephalosporanic acid derivatives of the general formula I R2-X-CH2-CONH - | - ^ New Ny CH2-R1 COOH wherein R 1 represents azido, thiadiazolylthio or oxadiazolylthio, wherein the 5 thiadiazole and oxadiazole nuclei substituted with C 1-6 alkyl or C 1-6 alkylthio, or tetrazolylthio, wherein the tetrazole cores are optionally substituted with C 1-6 alkyl, X represents a sulfur or oxygen atom or a single bond, and R 2 represents halogen or southnyl, tetrazolyl, oxadiazolyl, thienyl, phenyl or thiadiazolyl, which groups are optionally substituted with C1-6 alkyl or C1-6 alkylthio, however, where nitrile and tetrazolyl are only optionally substituted with C1-6 alkyl when X represents sulfur or oxygen, with the proviso that when R 2 is halogen, X represents a single bond, or salts thereof, thereby reacting a compound of the general formula II hooc-ch- (ch 2) 3-conh - τ 'SS I L_N J 11 ^ 1 2. gh2-r COOH
DK583670A 1969-11-17 1970-11-17 PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES DK147597C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9242169 1969-11-17
JP9242169 1969-11-17

Publications (2)

Publication Number Publication Date
DK147597B true DK147597B (en) 1984-10-15
DK147597C DK147597C (en) 1985-04-22

Family

ID=14053939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK583670A DK147597C (en) 1969-11-17 1970-11-17 PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES

Country Status (10)

Country Link
AT (1) AT309676B (en)
BE (1) BE758587A (en)
CH (1) CH569026A5 (en)
DE (1) DE2055796C2 (en)
DK (1) DK147597C (en)
ES (1) ES385581A1 (en)
FR (1) FR2069363A5 (en)
GB (1) GB1336155A (en)
NL (1) NL171708C (en)
SE (1) SE374923B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154889B (en) * 1971-12-23 1989-01-02 Fujisawa Pharmaceutical Co METHOD OF PRODUCING CEFAZOLINE

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793037A (en) * 1971-12-23 1973-06-20 Fujisawa Pharmaceutical Co PROCESS FOR THE PREPARATION OF 7-ACYLAMINO-3-SUBSTITUE-3-CEPHEM-4-CARBOXYLIC ACID DERIVATIVES AND NEW PRODUCTS THUS OBTAINED
GB1492435A (en) * 1974-08-30 1977-11-16 Squibb & Sons Inc Cephalosporins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL150798B (en) * 1967-08-07 1976-09-15 Koninklijke Gist Spiritus PROCESS FOR THE PREPARATION OF 7-AMINOCEPHALOSORANIC ACID AND ITS DERIVATIVES.
CH557381A (en) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co PROCESS FOR PRODUCING (DELTA) 3-CEPHEM COMPOUNDS.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154889B (en) * 1971-12-23 1989-01-02 Fujisawa Pharmaceutical Co METHOD OF PRODUCING CEFAZOLINE

Also Published As

Publication number Publication date
ES385581A1 (en) 1973-08-16
BE758587A (en) 1971-05-06
DE2055796A1 (en) 1971-05-27
DK147597C (en) 1985-04-22
NL171708B (en) 1982-12-01
NL171708C (en) 1983-05-02
AT309676B (en) 1973-08-27
FR2069363A5 (en) 1971-09-03
DE2055796C2 (en) 1982-04-01
CH569026A5 (en) 1975-11-14
SE374923B (en) 1975-03-24
NL7016844A (en) 1971-05-19
GB1336155A (en) 1973-11-07

Similar Documents

Publication Publication Date Title
KR20030078882A (en) Novel thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
DK145157B (en) ANALOGY PROCEDURE FOR PENICILLIN PREPARATION
CS247081B2 (en) Production method of cefemderivatives
US4230873A (en) Thiophene derivatives
CS262674B2 (en) Process for preparing heat stable crystalline cephalosporines
DK163584B (en) 7-AMINO-3-PROPENYLECEPHALOSPORIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DK147597B (en) PROCEDURE FOR THE PREPARATION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
JPH06345774A (en) Preparation of cephalosporin compound from reactive organic acid derivative
US4564676A (en) Process for preparing cephalosporin derivatives
KR890002107B1 (en) Process for preparing cephalosporin derivatives
US4242510A (en) Cephalosporin compounds and processes for the preparation thereof
US3704297A (en) 7 - (1,4 - cyclohexadienylacylamido)cephalosporanic acids and related compounds
KR0129567B1 (en) The process for preparation of cephalosporins
JPH0358351B2 (en)
KR850001206B1 (en) Process for preparing cephem derivatives
JPH05112564A (en) Phenylthiazole derivative
JP2004149412A (en) Method for producing 7-[2-(2-aminothiazol-4-yl)-2-lower alkoxycarbonylmethoxyiminoacetamido]-3-cephem compound
KR970005893B1 (en) Process for preparing cephalosporin compounds
KR830000710B1 (en) Process for preparing cefem compound
FR2461712A1 (en) 2-Oximino-acylamino cephem cpds. prodn. - by acylating 7-amino-cephem cpds. with complexes of 2-syn-oximino-acyl halide(s) and N,N-di:substd. amide(s)
KR840002142B1 (en) Process for preparing 7-alpha-methoxy-sephalosporin derivatives
KR790001175B1 (en) Process for preparing 7-amino cephalosporanic acid and their derivatives
JP2024505177A (en) Method for preparing 2-[2-(2-chlorothiazol-5-yl)-2-oxo-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one
JPH0546354B2 (en)
JPH027955B2 (en)

Legal Events

Date Code Title Description
PUP Patent expired